Stocks and Investing Stocks and Investing
Fri, July 24, 2015
Thu, July 23, 2015
Wed, July 22, 2015

Christopher Raymond Downgraded (BIIB) to Hold and Decreased Target to $410 on, Jul 22nd, 2015


Published on 2024-10-25 09:24:44 - WOPRAI, Christopher Raymond
  Print publication without navigation


Christopher Raymond of Piper Sandler, Downgraded "Biogen Inc." (BIIB) to Hold and Decreased Target from $485 to $410 on, Jul 22nd, 2015.

Christopher has made no other calls on BIIB in the last 4 months.



There are 3 other peers that have a rating on BIIB. Out of the 3 peers that are also analyzing BIIB, 2 agree with Christopher's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jay Olson of "Oppenheimer" Initiated at Hold on, Monday, April 27th, 2015
  • Christopher Marai of "Nomura" Maintained at Hold with Increased Target to $442 on, Monday, April 27th, 2015


This is the rating of the analyst that currently disagrees with Christopher


  • Geoffrey Porges of "Leerink Swann" Maintained at Buy with Decreased Target to $512 on, Thursday, June 11th, 2015
Contributing Sources